Chemoinformaics analysis of GUANIDINOACETIC ACID
| Molecular Weight | 117.108 | nRot | 2 |
| Heavy Atom Molecular Weight | 110.052 | nRig | 2 |
| Exact Molecular Weight | 117.054 | nRing | 0 |
| Solubility: LogS | -1.204 | nHRing | 0 |
| Solubility: LogP | -2.749 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 3 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 14.5816 |
| nHD | 3 | BPOL | 7.89045 |
| QED | 0.263 |
| Synth | 2.545 |
| Natural Product Likeliness | 0.529 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.731 |
| HIA | 0.014 |
| CACO-2 | -6.44 |
| MDCK | 0.00213455 |
| BBB | 0.759 |
| PPB | 0.0742876 |
| VDSS | 0.409 |
| FU | 0.838833 |
| CYP1A2-inh | 0.007 |
| CYP1A2-sub | 0.049 |
| CYP2c19-inh | 0.036 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.254 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.248 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.009 |
| CL | 3.454 |
| T12 | 0.734 |
| hERG | 0.053 |
| Ames | 0.055 |
| ROA | 0.065 |
| SkinSen | 0.417 |
| Carcinogencity | 0.06 |
| EI | 0.046 |
| Respiratory | 0.408 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.96825 |